Page last updated: 2024-12-06

tetradecanal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetradecanal is a saturated fatty aldehyde with the formula CH3(CH2)12CHO. It is a colorless liquid with a faint, fatty odor. Tetradecanal is a naturally occurring compound found in various plants and animals. Research on tetradecanal focuses on its role in various biological processes, including its potential as a signaling molecule, its involvement in cell growth and differentiation, and its impact on inflammation and immune responses. Studies on tetradecanal also explore its potential applications in various fields, such as cosmetics, pharmaceuticals, and food science.'

tetradecanal : A long-chain fatty aldehyde that is tetradecane in which two hydrogens attached to a terminal carbon are replaced by an oxo group. It is found in coriander. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID31291
CHEMBL ID2228569
CHEBI ID84067
SCHEMBL ID18604
MeSH IDM0071261

Synonyms (59)

Synonym
aldehyde c-14
fema no. 2763
tetradecyl aldehyde
einecs 204-692-7
nsc 66435
ai3-36199
brn 1765987
1-tetradecanal
1-tetradecyl aldehyde
myristaldehyde
NSC66435 ,
nsc-66435
n-tetradecanal
myristylaldehyde
tetradecylaldehyde
c-14 aldehyde, myristic
wln: vh13
aldehyde c-14, myristic
tetradecanal
124-25-4
myristic aldehyde
LMFA06000078
1LA3
511542-15-7
A805213
AKOS009158344
cas-124-25-4
tox21_202794
dtxcid101665
dtxsid1021665 ,
NCGC00260340-01
T2696
myristyl aldehyde
tetradecanaldehyde
FT-0674955
unii-44aj2lt15n
44aj2lt15n ,
4-01-00-03389 (beilstein handbook reference)
n-tetradecyl aldehyde
myristaldehyde [fcc]
myristaldehyde [fhfi]
peach aldehyde (c14)
tetradecane aldehyde
n-c13h27cho
ch3(ch2)12cho
SCHEMBL18604
chebi:84067 ,
CHEMBL2228569
tetradecanal, 98%
W-108409
mfcd00007019
GS-5775
CS-W004303
BBL102211
STL556010
fema 2763
Q6948297
AMY6110
H10276
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
long-chain fatty aldehydeA fatty aldehyde that has a chain length ranging from C13 to C22.
2,3-saturated fatty aldehydeAny fatty aldehyde that is saturated at positions 2 and 3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.21360.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency2.68900.000229.305416,493.5996AID743079
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, RecoverinBos taurus (cattle)Kd100.0000100.0000100.0000100.0000AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1811Experimentally measured binding affinity data derived from PDB2002Biochemistry, May-07, Volume: 41, Issue:18
Structure and calcium-binding studies of a recoverin mutant (E85Q) in an allosteric intermediate state.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2002Biochemistry, May-07, Volume: 41, Issue:18
Structure and calcium-binding studies of a recoverin mutant (E85Q) in an allosteric intermediate state.
AID1081323Nematicidal activity against Bursaphelenchus xylophilus at 0.5 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's2 (14.29)18.2507
2000's4 (28.57)29.6817
2010's5 (35.71)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.49 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.91 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]